Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02545504
Title GS-5745 With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gilead Sciences
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab

Andecaliximab

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | BEL


No variant requirements are available.